1. Home
  2. /
  3. Venture Capital
  4. /
  5. KU Leuven spin-off AstriVax...

Venture Capital

KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform

25 August 2022
AstriVax has raised the largest amount of seed capital in the history of KU Leuven spin-offs. The company will draw on technology developed at the KU Leuven Rega Institute to develop novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection against various viruses and other pathogens.


Press Release

Related News